Researchers have identified how cerebrovascular disease (CeVD) disrupts brain connectivity, contributing to cognitive decline ...

Acceptance of the Biologics License Application for subcutaneous Leqembi is based on results from the Clarity AD open-label ...

Zunveyl, an oral medication, is a better-tolerated version of galantamine for managing mild to moderate Alzheimer's symptoms.

Dec. 19, 2024 — Researchers have discovered a surprising link between a chronic gut infection caused by a common virus and the development of Alzheimer's disease in a subset of people.

The headset, developed by researchers at Cornell University in New York, could help reveal how the brain navigates and ...

Alzhemier’s disease could be diagnosed up to a decade earlier after the world’s biggest study of proteins is completed. The research, which will begin in the UK this month, will aim to pinpoint how ...

Among the key findings, age at diagnosis emerged as the strongest predictor of survival time. For women diagnosed at age 60, ...

In light of January being “Financial Wellness Month”, the Alzheimer’s Association is calling for families to make financial ...

Jan. 8, 2025 — Declining blood levels of two molecules that occur naturally in the body track closely with worsening Alzheimer's disease, particularly in women. Levels were found to drop ...

Alzheimer’s disease could be diagnosed up to a decade earlier after the world’s biggest study of proteins is completed. The research, which will begin in the UK this month, will aim to ...